What Lumexa Imaging (LMRI) Said on Its Q3 Earnings Call

Résumé détaillé

Lumexa Imaging (NASDAQ:LMRI) reported higher third-quarter revenue and a return to profitability as growth in advanced imaging procedures helped lift results across its outpatient…

Lumexa Imaging (NASDAQ:LMRI) reported higher third-quarter revenue and a return to profitability as growth in advanced imaging procedures helped lift results across its outpatient network and health system joint ventures.

The company narrowed its full-year adjusted EBITDA guidance and raised its adjusted earnings-per-share outlook, primarily because of a lower assumed tax rate. It also said it expects free cash flow to equal at least 30% of adjusted EBITDA for 2026, above its previous expectations.

Third-quarter consolidated revenue rose 5% from a year earlier to $272 million. Net income was $7.2 million, or $0.07 per share, compared with a net loss of $3.5 million in the prior-year quarter. Adjusted earnings were $0.26 per share.

Adjusted EBITDA increased to $62.6 million from $59.1 million a year earlier and rose 11% from the second quarter. The adjusted EBITDA margin was 23.0%, up from 22.8% a year earlier.

→ Lemonade's Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?

Systemwide advanced modality volumes grew 8.1% year over year and represented a record 38.2% of total volume, an increase of 145 basis points. Chief Executive Officer Caitlin Zulla said PET volume rose 19.5% from a year earlier.

Chief Financial Officer Tony Martin said advanced procedures generally reimburse at three to four times the rate of routine procedures. Total systemwide volume increased 4%, while outpatient systemwide revenue rose 7.7% and revenue per scan increased 3%.

Martin said the growth in revenue per scan reflected the shift toward advanced procedures and modest increases in contracted payer rates, partly offset by payer mix changes in a few markets.

Equity in earnings of unconsolidated affiliates, representing Lumexa's ownership share of income from joint venture sites, increased $4.9 million to $22.8 million. Martin attributed the strength in part to advanced modality growth and higher revenue per scan at joint venture locations.

Début de l'article, extrait de Yahoo Finance. Pour lire la suite, ouvrez l'article chez le média.